Rhythm Pharmaceuticals (RYTM) Reports In-Line Q4 EPS, provides guidance
Go back to Rhythm Pharmaceuticals (RYTM) Reports In-Line Q4 EPS, provides guidance| (NASDAQ: RYTM) | Delayed: 99.02 +1.01 (1.03%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $98.01 | 52 Week High | $ | |||
| Open | $101.17 | 52 Week Low | $ | |||
| Day High | $102.00 | P/E | N/A | |||
| Day Low | $98.80 | EPS | $ | |||
| Volume | 616,309 | |||||
